1. Home
  2. LQDA vs PTON Comparison

LQDA vs PTON Comparison

Compare LQDA & PTON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$37.80

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo Peloton Interactive Inc.

PTON

Peloton Interactive Inc.

HOLD

Current Price

$5.17

Market Cap

2.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
PTON
Founded
2004
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.6B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
LQDA
PTON
Price
$37.80
$5.17
Analyst Decision
Strong Buy
Buy
Analyst Count
11
13
Target Price
$41.00
$8.05
AVG Volume (30 Days)
1.1M
14.9M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
51.81
80.13
EPS
N/A
N/A
Revenue
$158,320,000.00
N/A
Revenue This Year
$278.87
N/A
Revenue Next Year
$57.13
$0.44
P/E Ratio
N/A
N/A
Revenue Growth
1031.18
N/A
52 Week Low
$11.85
$3.65
52 Week High
$46.67
$9.20

Technical Indicators

Market Signals
Indicator
LQDA
PTON
Relative Strength Index (RSI) 49.78 67.87
Support Level $31.75 $4.44
Resistance Level $39.19 $6.97
Average True Range (ATR) 2.12 0.28
MACD 0.09 0.08
Stochastic Oscillator 37.52 91.55

Price Performance

Historical Comparison
LQDA
PTON

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About PTON Peloton Interactive Inc.

Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product derives revenue from the portfolio of Connected Fitness Products and related accessories, as well as Precor-branded fitness products, delivery and installation services, Peloton Bike portfolio rental products, extended warranty agreements, branded apparel, and commercial service contracts. Subscription revenue is derived from monthly Subscription fees. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from International markets.

Share on Social Networks: